๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Relapse prevention treatment for liver transplant patients

โœ Scribed by Christopher C. Wagner; Deborah L. Haller; Mary Ellen Olbrisch

Publisher
Springer
Year
1996
Tongue
English
Weight
940 KB
Volume
3
Category
Article
ISSN
1068-9583

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Screening liver transplant patients for
Screening liver transplant patients for tolerance
โœ G. Alex Bishop; Rohan B. H. Williams ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 75 KB

A fraction of liver transplant recipients are able to discontinue all immunosuppressive therapies without rejecting their grafts and are said to be operationally tolerant to the transplant. However, accurate identification of these recipients remains a challenge. To design a clinically applicable mo

Liver transplantation for hepatocellular
Liver transplantation for hepatocellular carcinoma: The best treatment, but for which patient?
โœ M E Schwartz ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 188 KB ๐Ÿ‘ 2 views

propranolol in the prevention of variceal re-bleeding: preliminary results hemodynamics, that may identify subgroups of patients at of a multicenter randomized trial [Abstract]. HEPATOLOGY 1995;22:297A. high risk for hepatic deterioration and early mortality precip-14. Jalan R, Forrest EH, Redhead D

Nutrition for the liver transplant patie
Nutrition for the liver transplant patient
โœ Antonio J. Sanchez; Jaime Aranda-Michel ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 94 KB ๐Ÿ‘ 1 views

Patients with end-stage liver disease (ESLD) frequently have diverse abnormalities of carbohydrate, lipid, and protein metabolism that cause progressive deterioration of their clinical condition and lead to malnutrition. Malnutrition is almost universally present in patients with ESLD undergoing liv